A detailed history of Capital Advisory Group Advisory Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Capital Advisory Group Advisory Services, LLC holds 2,584 shares of AMGN stock, worth $673,493. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,584
Previous 2,569 0.58%
Holding current value
$673,493
Previous $802,000 3.74%
% of portfolio
0.33%
Previous 0.34%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$309.38 - $337.38 $4,640 - $5,060
15 Added 0.58%
2,584 $832,000
Q2 2024

Jul 22, 2024

BUY
$262.75 - $319.31 $132,163 - $160,612
503 Added 24.35%
2,569 $802,000
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $264,836 - $319,691
985 Added 91.12%
2,066 $587,000
Q4 2023

Jan 09, 2024

BUY
$255.7 - $288.46 $60,600 - $68,365
237 Added 28.08%
1,081 $311,000
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $184,540 - $229,112
844 New
844 $226,000
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $197,792 - $241,075
876 New
876 $211,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $67,136 - $74,711
-291 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$219.27 - $242.57 $63,807 - $70,587
291 New
291 $70,000
Q4 2021

Feb 15, 2022

SELL
$198.88 - $227.6 $96,456 - $110,386
-485 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $32,052 - $37,553
151 Added 45.21%
485 $103,000
Q2 2021

Nov 12, 2021

SELL
$233.58 - $259.14 $700 - $777
-3 Reduced 0.89%
334 $81,000
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $115,171 - $134,213
-519 Reduced 60.63%
337 $84,000
Q4 2020

Feb 18, 2021

SELL
$216.38 - $257.67 $353,348 - $420,775
-1,633 Reduced 65.61%
856 $197,000
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $252,718 - $281,043
1,077 Added 76.27%
2,489 $632,000
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $272,186 - $334,010
1,376 Added 3822.22%
1,412 $333,000
Q1 2020

May 18, 2020

BUY
$182.24 - $241.7 $6,560 - $8,701
36 New
36 $7,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $1,892 - $2,432
-10 Closed
0 $0
Q3 2019

May 28, 2020

SELL
$174.11 - $208.62 $3,656 - $4,381
-21 Reduced 67.74%
10 $2,000
Q4 2018

May 28, 2020

BUY
$178.4 - $208.25 $3,746 - $4,373
21 Added 210.0%
31 $6,000
Q1 2018

May 28, 2020

BUY
$169.43 - $198.0 $1,694 - $1,980
10 New
10 $2,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $139B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Advisory Group Advisory Services, LLC Portfolio

Follow Capital Advisory Group Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisory Group Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisory Group Advisory Services, LLC with notifications on news.